Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lite Strategy, Inc.MEIP · Entity 7396 | Chief Medical Officer | September 29, 2023 | October 12, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lite Strategy, Inc.
Report date September 29, 2023 · Filed October 12, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.01 · Expires 2033-09-29 | Direct | 30,000 |
Reported balance
After 2023-09-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-09-29 · Grant · Acquired 30,000 · Balance 30,000 F1: One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2023 Filed Oct 12, 2023 19:38 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000929638-23-002767 · form4.xml · derivative · entry 1 GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-09-29 F1 · derivative.exercise_date: One quarter of such options shall vest as of July 1, 2024, with monthly vesting on the first day of each of the next 36 calendar months beginning on August 1, 2024. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 16:17 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 560,000 | $0.00 Strike: $0.54 | $0.00 |
DisclosureSEC source: 0001567619-22-013787 · doc1.xml · derivative · entry 2 GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,000 Underlying: Common Stock · 560,000 shares Expires 2032-07-05 F2 · derivative.exercise_date: One-quarter of such options shall vest on July 5, 2023 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 5, 2023. Read SEC document |
| July 05, 2022 Filed Jul 7, 2022 16:17 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | Tax withholdingCommon Stock | 8,196 | $0.54 | $4,425.84 |
DisclosureSEC source: 0001567619-22-013787 · doc1.xml · nonDerivative · entry 1 GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,927 F1 · shares: Represents the number of shares withheld by and surrendered to the Issuer on July 5, 2022, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units. Read SEC document |
| July 01, 2021 Filed Jul 6, 2021 18:52 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 320,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-21-045645 · doc4.xml · derivative · entry 1 GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: One-quarter of such options shall vest on July 1, 2022, and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022. Read SEC document |
| May 03, 2021 Filed May 5, 2021 16:02 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001567619-21-009092 · doc1.xml · derivative · entry 1 GHALIE RICHARD G · CIK 0001156208 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-05-03 F1 · derivative.exercise_date: 1/4th of shares vest one-year from 5/03/2021, with the remaining balance of shares vesting in 36 equal amounts over three years. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.